Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine for Colorectal Cancer Prevention in Lynch Syndrome
NCT03070574Phase 2Terminated
- Start
- Nov 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of Salcrozine in colorectal cancer (CRC). Started Nov 2017; status: terminated.
02
Drugs
Salcrozine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03070574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070574.